This paper looked at the immunotherapy agent Durvalumab used in the perioperative period for resectable NSCLC. A total of 802 patients were enrolled in the study, of which 400 received Durvalumab and the remaining 402 a placebo. The two primary endpoints measured were event-free survival and pathological complete resection.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
November 9, 2023
This video demonstrates a thoracoscopic left superior segmentectomy using indocyanine green (ICG) in identifying the intersegmental plane.
November 1, 2023
This is a video demonstrating a right lower lobe apical segmentectomy performed by the new CMR Versius system.
October 26, 2023
This video demonstrates a total robotic left lower lobectomy. It was the first lobectomy performed with the Versius system in Chile.
October 24, 2023
With the release of the European Guidelines for the Surgical Management of Pure Ground-Glass Opacities and Part-Solid Nodules from EACTS and ESTS, Joel interviewed the study’s co-chairs René Petersen and Giuseppe Cardillo.
October 23, 2023
This video presents a case of uniportal pure robotic lingulectomy in a seventy-one-year-old male with localized lung cancer.
October 12, 2023
Lung cancer has the highest worldwide cancer mortality rate. Early non-small cell lung cancer accounts for 84 percent of cases, with curative surgical intervention being the standard treatment.
October 12, 2023
The European Association of Cardio-Thoracic Surgery and the European Society of Thoracic Surgeons has collaborated to produce a review on the management of pure ground-glass and part-solid pulmonary nodules.
October 4, 2023
A retrospective cohort analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database of 128,723 patients—who underwent pulmonary resection for non-small cell lung cancer between 2009 and 2019—identified 1,873 (1.5 percent) with interstitial lung disease.
September 15, 2023
In this session, five expert thoracic surgeons came together to present on thoracic malignancy and its surgical solutions. In this talk, Dr. Alan Sihoe, a thoracic surgeon at CUHK Medical Centre in Hong Kong, discusses his perspective on surgical techniques for advanced lung cancer treatment.